These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 16724371)

  • 1. Therapies for axial disease in psoriatic arthritis. A systematic review.
    Nash P
    J Rheumatol; 2006 Jul; 33(7):1431-4. PubMed ID: 16724371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axial psoriatic arthritis: an intriguing clinical entity or a subset of an intriguing disease?
    Lubrano E; Spadaro A
    Clin Rheumatol; 2012 Jul; 31(7):1027-32. PubMed ID: 22552858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapies for psoriatic enthesopathy. A systematic review.
    Ritchlin CT
    J Rheumatol; 2006 Jul; 33(7):1435-8. PubMed ID: 16724370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of ankylosing spondylitis spinal mobility measurements in the assessment of spinal involvement in psoriatic arthritis.
    Fernández-Sueiro JL; Willisch A; Pértega-Díaz S; Tasende JA; Fernández-Lopez C; Galdo F; Blanco FJ
    Arthritis Rheum; 2009 Mar; 61(3):386-92. PubMed ID: 19248134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis.
    Coates LC; Kavanaugh A; Mease PJ; Soriano ER; Laura Acosta-Felquer M; Armstrong AW; Bautista-Molano W; Boehncke WH; Campbell W; Cauli A; Espinoza LR; FitzGerald O; Gladman DD; Gottlieb A; Helliwell PS; Husni ME; Love TJ; Lubrano E; McHugh N; Nash P; Ogdie A; Orbai AM; Parkinson A; O'Sullivan D; Rosen CF; Schwartzman S; Siegel EL; Toloza S; Tuong W; Ritchlin CT
    Arthritis Rheumatol; 2016 May; 68(5):1060-71. PubMed ID: 26749174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measures of outcome in ankylosing spondylitis and other spondyloarthritides.
    van der Heijde DM; van der Linden S
    Baillieres Clin Rheumatol; 1998 Nov; 12(4):683-93. PubMed ID: 9928502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory joint manifestations are prevalent in psoriasis: prevalence study of joint and axial involvement in psoriatic patients, and evaluation of a psoriatic and arthritic questionnaire.
    Alenius GM; Stenberg B; Stenlund H; Lundblad M; Dahlqvist SR
    J Rheumatol; 2002 Dec; 29(12):2577-82. PubMed ID: 12465155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.
    Jadon DR; Sengupta R; Nightingale A; Lindsay M; Korendowych E; Robinson G; Jobling A; Shaddick G; Bi J; Winchester R; Giles JT; McHugh NJ
    Ann Rheum Dis; 2017 Apr; 76(4):701-707. PubMed ID: 27913376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic treatment of psoriatic arthritis and axial spondyloarthritis with traditional biologic and non-biologic DMARDs.
    Soriano ER; Acosta-Felquer ML; Luong P; Caplan L
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):793-806. PubMed ID: 25488785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Problems with definitions of disease patterns in psoriatic arthritis.
    Le Goff P
    J Rheumatol; 2006 Jan; 33(1):198-9; author reply 199. PubMed ID: 16395770
    [No Abstract]   [Full Text] [Related]  

  • 11. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force.
    Smolen JS; Schöls M; Braun J; Dougados M; FitzGerald O; Gladman DD; Kavanaugh A; Landewé R; Mease P; Sieper J; Stamm T; Wit M; Aletaha D; Baraliakos X; Betteridge N; Bosch FVD; Coates LC; Emery P; Gensler LS; Gossec L; Helliwell P; Jongkees M; Kvien TK; Inman RD; McInnes IB; Maccarone M; Machado PM; Molto A; Ogdie A; Poddubnyy D; Ritchlin C; Rudwaleit M; Tanew A; Thio B; Veale D; Vlam K; van der Heijde D
    Ann Rheum Dis; 2018 Jan; 77(1):3-17. PubMed ID: 28684559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment and treatment of psoriatic spondylitis.
    Nash P
    Curr Rheumatol Rep; 2009 Aug; 11(4):278-83. PubMed ID: 19691931
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
    Lubrano E; Spadaro A; Marchesoni A; Olivieri I; Scarpa R; D'Angelo S; Salvarani C; Mathieu A; Cauli A; Ferrara N; Helliwell P
    Clin Exp Rheumatol; 2011; 29(1):80-4. PubMed ID: 21345296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The involvement of the spine in psoriatic arthritis.
    Baraliakos X; Coates LC; Braun J
    Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S31-5. PubMed ID: 26471338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Axial disease in psoriatic arthritis and ankylosing spondylitis: a critical comparison.
    Feld J; Chandran V; Haroon N; Inman R; Gladman D
    Nat Rev Rheumatol; 2018 Jun; 14(6):363-371. PubMed ID: 29752461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early diagnostics and therapy of spondyloarthritis including psoriatric arthropathy].
    Märker-Hermann E; Sieper J
    Z Rheumatol; 2012 Jan; 71(1):17-8. PubMed ID: 22286351
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of Axial Involvement on Clinical Characteristics of Psoriatic Arthritis: Analysis from the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
    Mease PJ; Palmer JB; Liu M; Kavanaugh A; Pandurengan R; Ritchlin CT; Karki C; Greenberg JD
    J Rheumatol; 2018 Oct; 45(10):1389-1396. PubMed ID: 29961691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease activity measurements and monitoring in psoriatic arthritis and axial spondyloarthritis.
    Machado PM; Raychaudhuri SP
    Best Pract Res Clin Rheumatol; 2014 Oct; 28(5):711-28. PubMed ID: 25488780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of measurement properties of patient reported outcome measures in psoriatic arthritis: A GRAPPA-OMERACT initiative.
    Højgaard P; Klokker L; Orbai AM; Holmsted K; Bartels EM; Leung YY; Goel N; de Wit M; Gladman DD; Mease P; Dreyer L; Kristensen LE; FitzGerald O; Tillett W; Gossec L; Helliwell P; Strand V; Ogdie A; Terwee CB; Christensen R
    Semin Arthritis Rheum; 2018 Apr; 47(5):654-665. PubMed ID: 29037523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity of the bath ankylosing spondylitis disease activity index for the evaluation of disease activity in axial psoriatic arthritis.
    Fernández-Sueiro JL; Willisch A; Pértega-Díaz S; Tasende JA; Fernández-López JC; Villar NO; Galdo F; Blanco FJ
    Arthritis Care Res (Hoboken); 2010 Jan; 62(1):78-85. PubMed ID: 20191494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.